Plasma, gathered mainly from paid donations in the US, is the raw ingredient needed to produce CSL’s suite of lifesaving products, including its immunoglobulins, conventional haemophilia treatment and ...
Gift 5 articles to anyone you choose each month when you subscribe. Global biotech CSL says its US vaccines business will recover in the medium term when falling immunisation rates trigger a severe ...
Add articles to your saved list and come back to them any time. Biotech juggernaut CSL has big questions to answer when it reports 2023 earnings this week, including how it is managing costs in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback